Selected article for: "chest pain and hospital hospital"

Author: Liu, Xuemei; Lv, Jie; Gan, Lin; Zhang, Ying; Sun, Feng; Meng, Bo; Jheon, Andrew; Yan, Fang; Li, Bin; Xuan, Zhou; Ma, Xiumin; Wulasihana, Muhuyati
Title: Comparative Analysis of Clinical Characteristics, Imaging and Laboratory Findings of Different Age Groups with COVID-19.
  • Cord-id: qrh18gd4
  • Document date: 2020_1_1
  • ID: qrh18gd4
    Snippet: OBJECTIVE This study aims to provide scientific basis for rapid screening and early diagnosis of the coronavirus disease 2019 (COVID-19) through analysing the clinical characteristics and early imaging/laboratory findings of the inpatients. METHODS Three hundred and three patients with laboratory-confirmed COVID-19 from the East Hospital of People's Hospital of Wuhan University (Wuhan, China) were selected and divided into four groups: youth (20-40 years, n = 64), middle-aged (41-60 years, n = 8
    Document: OBJECTIVE This study aims to provide scientific basis for rapid screening and early diagnosis of the coronavirus disease 2019 (COVID-19) through analysing the clinical characteristics and early imaging/laboratory findings of the inpatients. METHODS Three hundred and three patients with laboratory-confirmed COVID-19 from the East Hospital of People's Hospital of Wuhan University (Wuhan, China) were selected and divided into four groups: youth (20-40 years, n = 64), middle-aged (41-60 years, n = 89), older (61-80 years, n = 118) and elderly (81-100 years, n = 32). The clinical characteristics and imaging/laboratory findings including chest computed tomography (CT), initial blood count, C-reactive protein [CRP]), procalcitonin (PCT) and serum total IgE were captured and analysed. RESULTS (1) The first symptoms of all age groups were primarily fever (76%), followed by cough (12%) and dyspnoea (5%). Beside fever, the most common initial symptom of elderly patients was fatigue (13%). (2) Fever was the most common clinical manifestation (80%), with moderate fever being the most common (40%), followed by low fever in patients above 40 years old and high fever in those under 40 years (35%). Cough was the second most common clinical manifestation and was most common (80%) in the middle-aged. Diarrhoea was more common in the middle-aged (21%) and the older (19%). Muscle ache was more common in the middle-aged (15%). Chest pain was more common in the youth (13%), and 13% of the youth had no symptoms. (3) The proportion of patients with comorbidities increased with age. (4) Seventy-one per cent of the patients had positive reverse transcription-polymerase chain reaction results and 29% had positive chest CT scans before admission to the hospital. (5) Lesions in all lobes of the lung were observed as the main chest CT findings (76%). (6) Decrease in lymphocytes and increase in monocytes were common in the patients over 40 years old but rare in the youth. Eosinophils (50%), red blood cells (39%) and haemoglobin (40%) decreased in all age groups. (7) The proportion of patients with CRP and PCT elevation increased with age. (8) Thirty-nine per cent of the patients had elevated IgE, with the highest proportion in the old (49%). CONCLUSION The clinical characteristics and imaging/laboratory findings of COVID-19 patients vary in different age groups. Personalised criteria should be formulated according to different age groups in the early screening and diagnosis stage.

    Search related documents:
    Co phrase search for related documents
    • acid detection and lung involvement: 1, 2
    • acid detection and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acid detection and lymphocyte decrease: 1
    • admission diagnosis and lung involvement: 1, 2, 3
    • admission diagnosis and lymphocyte count: 1, 2, 3, 4, 5, 6, 7
    • lobe involvement and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lobe involvement and lung lobe involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lobe involvement and lung lobe involvement extent: 1, 2, 3, 4, 5
    • lobe involvement and lymphocyte count: 1, 2, 3, 4
    • lung involvement and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lung involvement and lymphocyte decrease: 1, 2
    • lung lobe involvement and lymphocyte count: 1, 2